Literature DB >> 12970143

Activin A is an autocrine activator of rat pancreatic stellate cells: potential therapeutic role of follistatin for pancreatic fibrosis.

N Ohnishi1, T Miyata, H Ohnishi, H Yasuda, K Tamada, N Ueda, H Mashima, K Sugano.   

Abstract

BACKGROUND AND AIM: The present study was conducted to examine the effect of activin A on activation of rat pancreatic stellate cells (PSCs).
METHODS: PSCs were prepared from rat pancreas using collagenase digestion and centrifugation with Nycodenz gradient. Activation of PSCs was examined by determining smooth muscle actin expression with western blotting. The presence of activin A receptors in PSCs was investigated by reverse transcription-polymerase chain reaction (RT-PCR), western blotting, and immunocytochemistry. Expression of activin A and transforming growth factor beta (TGF-beta) mRNA was examined by RT-PCR. Activin A and TGF-beta peptide concentrations were examined with ELISA. Existence of activin A peptide in PSCs was investigated by immunocytochemistry. Collagen secretion was determined by Sirius red dye binding.
RESULTS: Activin A receptors I and IIa were present in PSCs. PSCs expressed activin A mRNA and secreted activin A. Activin A enhanced PSC activation and collagen secretion in a dose dependent manner. TGF-beta and activin A increased each other's secretion and mRNA expression of PSCs. Follistatin decreased TGF-beta mRNA expression and TGF-beta secretion of PSCs, and inhibited both PSC activation and collagen secretion.
CONCLUSION: Activin A is an autocrine activator of PSCs. Follistatin can inhibit PSC activation and collagen secretion by blocking autocrined activin A and decreasing TGF-beta expression and secretion of PSCs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12970143      PMCID: PMC1773818          DOI: 10.1136/gut.52.10.1487

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  36 in total

1.  Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis.

Authors:  M V Apte; P S Haber; S J Darby; S C Rodgers; G W McCaughan; M A Korsten; R C Pirola; J S Wilson
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

2.  Intravenous administration of follistatin: delivery to the liver and effect on liver regeneration after partial hepatectomy.

Authors:  K Kogure; Y Q Zhang; M Kanzaki; W Omata; T Mine; I Kojima
Journal:  Hepatology       Date:  1996-08       Impact factor: 17.425

3.  Localization and cellular sources of activins in normal and fibrotic rat liver.

Authors:  P J De Bleser; T Niki; G Xu; V Rogiers; A Geerts
Journal:  Hepatology       Date:  1997-10       Impact factor: 17.425

4.  Extracellular matrix is reduced by inhibition of transforming growth factor beta1 in pancreatitis in the rat.

Authors:  A Menke; H Yamaguchi; T M Gress; G Adler
Journal:  Gastroenterology       Date:  1997-07       Impact factor: 22.682

5.  Expression of interleukin-10 by in vitro and in vivo activated hepatic stellate cells.

Authors:  S C Wang; M Ohata; L Schrum; R A Rippe; H Tsukamoto
Journal:  J Biol Chem       Date:  1998-01-02       Impact factor: 5.157

6.  Expression of activin A is increased in cirrhotic and fibrotic rat livers.

Authors:  M Sugiyama; T Ichida; T Sato; T Ishikawa; Y Matsuda; H Asakura
Journal:  Gastroenterology       Date:  1998-03       Impact factor: 22.682

7.  Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture.

Authors:  M V Apte; P S Haber; T L Applegate; I D Norton; G W McCaughan; M A Korsten; R C Pirola; J S Wilson
Journal:  Gut       Date:  1998-07       Impact factor: 23.059

8.  Betacellulin and activin A coordinately convert amylase-secreting pancreatic AR42J cells into insulin-secreting cells.

Authors:  H Mashima; H Ohnishi; K Wakabayashi; T Mine; J Miyagawa; T Hanafusa; M Seno; H Yamada; I Kojima
Journal:  J Clin Invest       Date:  1996-04-01       Impact factor: 14.808

9.  Identification, culture, and characterization of pancreatic stellate cells in rats and humans.

Authors:  M G Bachem; E Schneider; H Gross; H Weidenbach; R M Schmid; A Menke; M Siech; H Beger; A Grünert; G Adler
Journal:  Gastroenterology       Date:  1998-08       Impact factor: 22.682

10.  Hypoplasia of pancreatic islets in transgenic mice expressing activin receptor mutants.

Authors:  T Yamaoka; C Idehara; M Yano; T Matsushita; T Yamada; S Ii; M Moritani; J Hata; H Sugino; S Noji; M Itakura
Journal:  J Clin Invest       Date:  1998-07-15       Impact factor: 14.808

View more
  25 in total

Review 1.  The pancreatic stellate cell: a star on the rise in pancreatic diseases.

Authors:  M Bishr Omary; Aurelia Lugea; Anson W Lowe; Stephen J Pandol
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

2.  Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis.

Authors:  L Xu; A Y Hui; E Albanis; M J Arthur; S M O'Byrne; W S Blaner; P Mukherjee; S L Friedman; F J Eng
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

Review 3.  Therapeutic potential of perineural invasion, hypoxia and desmoplasia in pancreatic cancer.

Authors:  Han Liu; Qingyong Ma; Qinhong Xu; Jianjun Lei; Xuqi Li; Zheng Wang; Erxi Wu
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

4.  Therapeutic targeting of the PDGF and TGF-beta-signaling pathways in hepatic stellate cells by PTK787/ZK22258.

Authors:  Yuqing Liu; Xiao Ming Wen; Eric Lik Hang Lui; Scott L Friedman; Wei Cui; Nancy Pei Shan Ho; Lei Li; Tao Ye; Sheung Tat Fan; Hui Zhang
Journal:  Lab Invest       Date:  2009-08-10       Impact factor: 5.662

5.  Effects of angiotensin II receptor antagonist, Losartan on the apoptosis, proliferation and migration of the human pancreatic stellate cells.

Authors:  Wen-Bin Liu; Xing-Peng Wang; Kai Wu; Ru-Ling Zhang
Journal:  World J Gastroenterol       Date:  2005-11-07       Impact factor: 5.742

6.  A phase 1/2a follistatin gene therapy trial for becker muscular dystrophy.

Authors:  Jerry R Mendell; Zarife Sahenk; Vinod Malik; Ana M Gomez; Kevin M Flanigan; Linda P Lowes; Lindsay N Alfano; Katherine Berry; Eric Meadows; Sarah Lewis; Lyndsey Braun; Kim Shontz; Maria Rouhana; Kelly Reed Clark; Xiomara Q Rosales; Samiah Al-Zaidy; Alessandra Govoni; Louise R Rodino-Klapac; Mark J Hogan; Brian K Kaspar
Journal:  Mol Ther       Date:  2014-10-17       Impact factor: 11.454

Review 7.  Signal transduction in pancreatic stellate cells.

Authors:  Atsushi Masamune; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2009-03-07       Impact factor: 7.527

8.  Acinar cell-specific knockout of the PTHrP gene decreases the proinflammatory and profibrotic responses in pancreatitis.

Authors:  Vandanajay Bhatia; Cristiana Rastellini; Song Han; Judith F Aronson; George H Greeley; Miriam Falzon
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-07-17       Impact factor: 4.052

Review 9.  Mechanisms of pancreatic fibrosis and applications to the treatment of chronic pancreatitis.

Authors:  Kyoko Shimizu
Journal:  J Gastroenterol       Date:  2008-11-18       Impact factor: 7.527

Review 10.  TGFB1/INHBA Homodimer/Nodal-SMAD2/3 Signaling Network: A Pivotal Molecular Target in PDAC Treatment.

Authors:  Mai Abdel Mouti; Siim Pauklin
Journal:  Mol Ther       Date:  2021-01-09       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.